Clever Leaves Holdings (Clever Leaves Holdings) EBITDA Margin % : -98.99% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Clever Leaves Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Clever Leaves Holdings's EBITDA for the three months ended in Dec. 2023 was $-4.59 Mil. Clever Leaves Holdings's Revenue for the three months ended in Dec. 2023 was $4.64 Mil. Therefore, Clever Leaves Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was -98.99%.

Clever Leaves Holdings EBITDA Margin % Historical Data

The historical data trend for Clever Leaves Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clever Leaves Holdings EBITDA Margin % Chart

Clever Leaves Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-532.55

-147.28

-223.46

-230.04

-96.66

Clever Leaves Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial												-153.63	-88.16	-52.34	-159.48	-98.99

Competitive Comparison of Clever Leaves Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Clever Leaves Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clever Leaves Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Clever Leaves Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Clever Leaves Holdings's EBITDA Margin % falls into.

Clever Leaves Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Clever Leaves Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-16.835	/	17.417
	=	-96.66 %

Clever Leaves Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-4.591	/	4.638
	=	-98.99 %

Clever Leaves Holdings (OTCPK:CLVRW) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Clever Leaves Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Clever Leaves Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clever Leaves Holdings (Clever Leaves Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Clever Leaves Holdings Inc (OTCPK:CLVRW) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

CLVR:USA

Address

19-B Parque Industrial Tibitoc, Tocancipá, Cundinamarca, Bodega, Colombia, BC, CAN

Website

https://www.cleverleaves.com

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments, 1. The Cannabinoid operating segment: is comprised of the Company's cultivation, extraction, and commercialization of cannabinoid products. 2. Non-Cannabinoid operating segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements.